Back to Search
MINH-THU JOST, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1588037600Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RPH-0014910(OR)
Research & Publications (20)
Toxin-resistant sodium channels: parallel adaptive evolution across a complete gene family.
PMID 18258611·Mol Biol Evol·2008
7-preclinical
Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.
PMID 17717143·Am J Pathol·2007
7-preclinical
Synthesis, and structural and biological studies of efrapeptin C analogues.
PMID 17589859·Chem Biodivers·2007
8-other
Phylogeny of Ensifera (Hexapoda: Orthoptera) using three ribosomal loci, with implications for the evolution of acoustic communication.
PMID 16298145·Mol Phylogenet Evol·2006
7-preclinical
Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice.
PMID 16707448·Cancer Res·2006
7-preclinical
The concept of functional peptidomics for the discovery of bioactive peptides in cell culture models.
PMID 16464163·Comb Chem High Throughput Screen·2005
8-other
Divergent effects of GM-CSF and TGFbeta1 on bone marrow-derived macrophage arginase-1 activity, MCP-1 expression, and matrix metalloproteinase-12: a potential role during arteriogenesis.
PMID 14525945·FASEB J·2003
7-preclinical
In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma.
PMID 18940185·Biochem Pharmacol·2009
7-preclinical
Inhibition of gamma-thrombin-induced human platelet aggregation by histone H1subtypes and H1.3 fragments.
PMID 19637099·Platelets·2009
8-other
Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors--a proof of concept study.
PMID 18804500·Peptides·2008
7-preclinical
Quantification of in vivo tumor invasion and vascularization by computerized image analysis.
PMID 17976661·Microvasc Res·2008
4-observational
Matrix metalloproteinases at cancer tumor-host interface.
PMID 17625931·Semin Cell Dev Biol·2008
6-review
Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors.
PMID 18753414·Carcinogenesis·2008
7-preclinical
Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
PMID 17644433·Trends Mol Med·2007
6-review
Lipid chain-length dependence for incorporation of alamethicin in membranes: electron paramagnetic resonance studies on TOAC-spin labeled analogs.
PMID 17351010·Biophys J·2007
8-other
Total syntheses in solution of TOAC-labelled alamethicin F50/5 analogues.
PMID 17589860·Chem Biodivers·2007
8-other
Conformational analysis of TOAC-labelled alamethicin F50/5 analogues.
PMID 17589864·Chem Biodivers·2007
8-other
Solvent dependence of the rotational diffusion of TOAC-spin-labeled alamethicin.
PMID 17589865·Chem Biodivers·2007
8-other
Supramolecular structure of self-assembling alamethicin analog studied by ESR and PELDOR.
PMID 17589866·Chem Biodivers·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20000 SE HIGHWAY 212
DAMASCUS, OR 97089 - Phone
- (503) 558-1415
Quick Facts
- NPI
- 1588037600
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile